COHEN LAWRENCE B - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 29 filers reported holding AC IMMUNE SA in Q3 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
COHEN LAWRENCE B ownership history of AC IMMUNE SA
ValueSharesWeighting
Q3 2023$36,623
-3.6%
12,8500.0%0.02%
+4.2%
Q2 2023$37,972
+26.3%
12,8500.0%0.02%
+20.0%
Q1 2023$30,069
+14.7%
12,8500.0%0.02%
+42.9%
Q4 2022$26,214
-36.1%
12,8500.0%0.01%
-56.2%
Q3 2022$41,000
-10.9%
12,8500.0%0.03%
-3.0%
Q2 2022$46,000
-9.8%
12,8500.0%0.03%
+10.0%
Q1 2022$51,000
-20.3%
12,8500.0%0.03%
+20.0%
Q4 2021$64,000
-25.6%
12,8500.0%0.02%
-44.4%
Q3 2021$86,000
-15.7%
12,8500.0%0.04%
-13.5%
Q2 2021$102,000
+4.1%
12,8500.0%0.05%
-1.9%
Q1 2021$98,000
+48.5%
12,8500.0%0.05%
+43.2%
Q4 2020$66,000
+4.8%
12,8500.0%0.04%
-2.6%
Q3 2020$63,000
-30.0%
12,850
-3.7%
0.04%
-36.7%
Q2 2020$90,000
-2.2%
13,3500.0%0.06%
-16.7%
Q1 2020$92,000
-19.3%
13,3500.0%0.07%
+7.5%
Q4 2019$114,000
+72.7%
13,3500.0%0.07%
+55.8%
Q3 2019$66,000
-10.8%
13,3500.0%0.04%
-15.7%
Q2 2019$74,000
+10.4%
13,3500.0%0.05%
+8.5%
Q1 2019$67,000
-46.8%
13,3500.0%0.05%
-52.0%
Q4 2018$126,000
+5.9%
13,350
-10.1%
0.10%
+21.0%
Q3 2018$119,000
-38.0%
14,850
-27.7%
0.08%
-40.9%
Q2 2018$192,000
-9.4%
20,5500.0%0.14%
-3.5%
Q1 2018$212,000
+26.9%
20,550
+57.5%
0.14%
+34.0%
Q4 2017$167,000
+14.4%
13,0500.0%0.11%
+11.6%
Q3 2017$146,000
-50.8%
13,050
-61.3%
0.10%
-50.0%
Q2 2017$297,00033,7500.19%
Other shareholders
AC IMMUNE SA shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 7,504,579$57,110,0002.14%
EcoR1 Capital, LLC 3,648,163$27,763,0001.23%
Artal Group S.A. 1,000,000$7,610,0000.13%
Temasek Holdings (Private) Ltd 2,614,095$19,893,0000.08%
Connacht Asset Management LP 44,026$335,0000.07%
COHEN LAWRENCE B 12,850$98,0000.05%
ALPINE WOODS CAPITAL INVESTORS, LLC 50,000$381,0000.04%
Compagnie Lombard Odier SCmA 225,359$1,715,0000.04%
Ikarian Capital, LLC 119,803$911,0000.03%
Banque Cantonale Vaudoise 71,430$544,0000.03%
View complete list of AC IMMUNE SA shareholders